AnalystsInsight

Benjamin Budish (Barclays): Analyst Track Record and Price‑Target Accuracy

How often Benjamin Budish’s price targets were reached, how fast, and what the stocks did after each call: a 7‑year backtest of 2,181 ratings, compared with the average Wall Street analyst.

Published Updated 3 min readHow we research

What changed since Oct 12

Exent re-checks this page every day. Ratings appear 30 days after they are published; live calls are in Gems.

#924 rank (was #807)+11 new ratings (CBOE, ARES, VCTR)4.6★ rating (was 4.7★)

Key takeaways

  • Benjamin Budish ranks #834 of 1,000 analysts in Exent’s scoring (4.6★).
  • 67.3% of price targets were reached over 7 years, versus 52.4% for the average analyst.
  • Median time to reach a target: 70 days; 81.8% of calls were up 12 months later.
  • Most‑covered stocks: HOOD, CME, SCHW, IBKR.
  • Free on Exent: Benjamin Budish’s full record, with ratings 3 days after publication.

Benjamin Budish’s track record at a glance

Benjamin Budish of Barclays ranks #834 of the 1,000 analysts Exent scores, with a 4.6★ rating and a focus on financials. Over a 7‑year lookback, 67.3% of Benjamin’s price targets were reached, 14.9 points above the 52.4% average across all analysts.

MetricBenjamin BudishAll analysts
Price‑target hit rate67.3%52.4%
Median days to hit target70 days91 days
Calls up after 12 months81.8%64.0%
Median 12‑month return of calls+28.9%+13.4%
Hit rate, last 2 years59.7%—
Average worst drop after a call−16.1%—
Ratings in the sample2,181—
Stocks covered32—

The full records of Exent’s top 90 analysts and the top 50 of each sector, and the stocks where several of them agree right now, are members‑only in Exent Gems.

How fast price targets were reached

Time to reach the targetBenjamin Budish
Under 30 days30.9%
30–90 days27.6%
90–180 days22.7%
Over 180 days18.8%

Share of the targets that were reached, by how long they took. Targets are usually set for 12 months.

Stocks Benjamin Budish covers most

StockRatings in the sample
HOOD40
CME22
SCHW21
IBKR21
LPLA18
COIN18
BX17
APO16

In the past year Benjamin’s ratings were 62% Buy, 29% Hold and 9% Sell.

Benjamin Budish’s latest ratings

DateStockActionRatingPrice target
Sep 17, 2026CBOEReiterated: BuyBuy$354.00
Sep 17, 2026ARESReiterated: BuyBuy$139.00
Sep 17, 2026VCTRReiterated: HoldHold$112.00
Sep 16, 2026TPGReiterated: BuyBuy$64.00
Sep 16, 2026KKRReiterated: BuyBuy$135.00
Sep 16, 2026BXReiterated: HoldHold$128.00
Sep 16, 2026SCHWReiterated: BuyBuy$125.00
Sep 15, 2026STEPReiterated: BuyBuy$62.00
Sep 15, 2026APOReiterated: BuyBuy$157.00
Sep 15, 2026NDAQReiterated: BuyBuy$111.00
Sep 15, 2026OWLReiterated: HoldHold$10.00
Sep 2, 2026IBKRReiterated: BuyBuy$114.00
  • Sep 17, 2026
    Stock
    CBOE
    Action
    Reiterated: Buy
    Rating
    Buy
    Price target
    $354.00
  • Sep 17, 2026
    Stock
    ARES
    Action
    Reiterated: Buy
    Rating
    Buy
    Price target
    $139.00
  • Sep 17, 2026
    Stock
    VCTR
    Action
    Reiterated: Hold
    Rating
    Hold
    Price target
    $112.00
  • Sep 16, 2026
    Stock
    TPG
    Action
    Reiterated: Buy
    Rating
    Buy
    Price target
    $64.00
  • Sep 16, 2026
    Stock
    KKR
    Action
    Reiterated: Buy
    Rating
    Buy
    Price target
    $135.00
  • Sep 16, 2026
    Stock
    BX
    Action
    Reiterated: Hold
    Rating
    Hold
    Price target
    $128.00
  • Sep 16, 2026
    Stock
    SCHW
    Action
    Reiterated: Buy
    Rating
    Buy
    Price target
    $125.00
  • Sep 15, 2026
    Stock
    STEP
    Action
    Reiterated: Buy
    Rating
    Buy
    Price target
    $62.00
  • Sep 15, 2026
    Stock
    APO
    Action
    Reiterated: Buy
    Rating
    Buy
    Price target
    $157.00
  • Sep 15, 2026
    Stock
    NDAQ
    Action
    Reiterated: Buy
    Rating
    Buy
    Price target
    $111.00
  • Sep 15, 2026
    Stock
    OWL
    Action
    Reiterated: Hold
    Rating
    Hold
    Price target
    $10.00
  • Sep 2, 2026
    Stock
    IBKR
    Action
    Reiterated: Buy
    Rating
    Buy
    Price target
    $114.00

Benjamin’s ratings are free on Exent 3 days after publication. Exent Gems has them the same day, with the calls of the top‑ranked analysts and the stocks where several of them agree.

How Exent scores analysts

Exent replays every rating with a price target over a 7‑year lookback: was the target reached, how long it took, and what the stock returned 1, 3, 6 and 12 months after the call. The star rating and rank combine success rate, average return and the number of ratings, so a few lucky calls do not make a top analyst. Statistics as of Jun 24, 2026; ranking updated Oct 20, 2026. How accurate are analyst price targets overall?

Past performance does not guarantee future results. Historical figures are calculated by Exent from market data and are for education only; they are not investment advice or a recommendation to buy or sell any security.

Follow the analysts with the best records

  1. Exent Gems shows Benjamin Budish’s live ratings and those of the top‑ranked analysts, without the 30‑day delay used on this page.
  2. Gems are the stocks where several 4★+ analysts agree: Exent’s shortlist of high‑conviction ideas.
  3. Check any idea against your own portfolio: correlation, concentration and crash exposure before you buy.

Exent is our product. Educational content, not investment advice.

Frequently asked questions

By Exent’s scoring Benjamin Budish ranks #834 of 1,000 with a 4.6★ rating. 67.3% of price targets were reached over a 7-year lookback (all analysts: 52.4%), and 81.8% of calls were up 12 months later. Past accuracy does not guarantee future accuracy.

Benjamin Budish’s success rate is 54.4% by the ranking source and 67.3% by Exent’s price-target hit-rate backtest, with a median of 70 days to reach a target.

Benjamin Budish (Barclays) covers 32 stocks, mostly in financials. The most frequently rated are HOOD, CME, SCHW, IBKR, LPLA.

Get the picks Wall Street’s best analysts agree on.

Exent tracks 4,000+ analysts, keeps only the elite few with proven records, and surfaces the Gems where they agree.

See this week’s GemsLimited offer$1.95 for full access· full access

Educational content, not investment advice. Examples are illustrative; past performance does not guarantee future results.

DISCLAIMER: Exent AI is an informational research platform and does not provide investment advice, financial advice, or act as an investment adviser, broker-dealer, or fiduciary. All content, analytics, and model outputs are provided for educational and informational purposes only and should not be relied upon as a recommendation to buy, sell, or hold any financial instrument. Investing involves risk, including the possible loss of principal. Exent AI does not execute trades, hold customer funds, or provide brokerage services. Past performance and hypothetical results are not indicative of future results. Third-party data and AI-generated outputs may be incomplete or inaccurate.